Insulet (PODD) Cash from Investing Activities (2010 - 2026)

Insulet (PODD) reported Cash from Investing Activities of -$27.7 million for Q1 2026, down 77.56% on a YoY basis from -$123.5 million in Q1 2025, and up 81.87% quarter-over-quarter from -$152.8 million in Q4 2025.

Insulet (PODD) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Insulet has reported Cash from Investing Activities for 17 years, with the latest figure at -$27.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 77.56% year-over-year to -$27.7 million; the trailing twelve-month figure through Mar 2026 stood at -$234.8 million (down 70.39% YoY), and the FY2025 full-year result was -$222.7 million, down 52.33% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$27.7 million, up from -$152.8 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$15.6 million in Q1 2025, with the low at -$152.8 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$41.6 million across 5 years, with a median of -$29.3 million in 2024.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 177.87% — and 2023, when it soared 64.25%.
  • Insulet's Cash from Investing Activities stood at -$88.4 million in 2022, then soared by 64.25% to -$31.6 million in 2023, then sank by 115.19% to -$68.0 million in 2024, then slumped by 124.71% to -$152.8 million in 2025, then soared by 81.87% to -$27.7 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$27.7 million (Q1 2026), -$152.8 million (Q4 2025), and -$31.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -20.32 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -185.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -2.50 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -217.20 Mn
10 Insulet 10.20 Bn 9.72 Bn 529.10 Mn -27.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -27.70 Mn
Mar 31, 2026 -27.70 Mn
Dec 31, 2025 -152.80 Mn
Dec 31, 2025 -152.80 Mn
Sep 30, 2025 -31.00 Mn
Sep 30, 2025 -31.00 Mn
Jun 30, 2025 -23.30 Mn
Jun 30, 2025 -23.30 Mn
Mar 31, 2025 -15.60 Mn
Mar 31, 2025 -15.60 Mn
Dec 31, 2024 -68.00 Mn
Dec 31, 2024 -68.00 Mn
Sep 30, 2024 -29.30 Mn
Sep 30, 2024 -29.30 Mn
Jun 30, 2024 -24.90 Mn
Jun 30, 2024 -24.90 Mn
Mar 31, 2024 -24.00 Mn
Mar 31, 2024 -24.00 Mn
Dec 31, 2023 -31.60 Mn
Dec 31, 2023 -31.60 Mn